I’ve spent years listening to behavioral health providers describe the gap between the care they want to deliver and the systems they’re working with. That gap shows up everywhere, but nowhere is it more consequential than in opioid treatment programs.
OTPs operate at a level of clinical and regulatory complexity that most healthcare settings never encounter. High-volume dispensing. Strict DEA requirements. Real-time clinical decisions made in the middle of a busy morning clinic. The stakes are not abstract. The people walking through those doors are in active treatment for opioid use disorder, and what happens in that interaction matters enormously.
The technology supporting this work has not matched its importance.
This is not a technology problem. It is a prioritization problem. The behavioral health field has long tolerated fragmented, disconnected infrastructure in substance use treatment that it would not accept in other areas of care. Providers have adapted because they had to. But adapting to a broken system is not the same as having one that works.
That is what we set out to change.
What We Built and Why
SMARTdispense™ is a new module inside SmartCare™, our integrated EHR and practice management platform, built specifically for the workflows that define OTP operations. Front-desk check-in, dosing, pump integration, inventory management, and compliance documentation, all live within the same platform that clinical and billing teams are already using every day.
The integration matters more than any individual feature ever could. When the dispensing workflow lives in the same system as the clinical record, care teams are not toggling between platforms or reconciling information after the fact. The right information is available at the point of dispensing; at the moment it is needed.
We also built clinical safeguards directly into the workflow because that is where they belong. Dose-threshold confirmations. Toxicology screening requirements. Configurable holds. Titration and taper support. These are not add-ons. They are built into how SMARTdispense™ was designed from the beginning.
On the compliance side, SMARTdispense™ supports DEA and regulatory reporting, audit-ready documentation, and downtime workflows that maintain accurate records even when equipment is temporarily unavailable. Medication inventory is tracked at the bottle and lot level, covering methadone, buprenorphine, and naloxone.
It does what OTP programs have needed their technology to do for a long time.
Already in Production
SMARTdispense™ is live at Tacoma-Pierce County Health Department in Washington, Community Behavioral Health Clinic in Illinois, and Helio Health in New York, with additional implementations scheduled throughout 2026.
Watching a clinical team go live on new technology is always a useful reminder of what we are building toward. When the system works the way it should; it disappears. The team stops thinking about the workflow. They focus on the patient. That is the standard we hold ourselves to, not a long feature list, but whether the work of delivering care is genuinely better.
Why This Moment Matters
The opioid crisis has not gone away. The organizations on the front lines of the response are doing serious, difficult, high-stakes work. They deserve infrastructure that reflects that.
We built SMARTdispense™ because we believe that standard is overdue. And we are committed to continuing to raise it.
If you are leading an OTP and want to understand what this could mean for your organization, we welcome the conversation.
Navid Asgari is Chief Executive Officer of Streamline Healthcare Solutions.
